Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evexar Medical was a medical device company focused on developing minimally invasive surgical technologies for colorectal health. Spun out from University College London (UCL), the company's flagship product was the HALO (Hemorrhoidal Artery Ligation Operation) device, which uses Doppler ultrasound to identify and ligate hemorrhoidal arteries. This technology provided a less painful alternative to traditional hemorrhoidectomy and significantly reduced patient recovery times. In September 2010, the company was acquired by Cook Medical, a global leader in minimally invasive medical devices, to expand its surgical product portfolio. The HALO technology has since been integrated into Cook Medical's global surgery business unit.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evexar Medical.